These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 21541048)
21. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways. Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339 [No Abstract] [Full Text] [Related]
22. Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma. Mayinuer A; Yasen M; Mogushi K; Obulhasim G; Xieraili M; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S Ann Surg Oncol; 2013 Jan; 20(1):305-17. PubMed ID: 23064776 [TBL] [Abstract][Full Text] [Related]
23. Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions. Davidson B; Berner A; Trope' CG; Wang TL; Shih IM Hum Pathol; 2007 Jul; 38(7):1030-1036. PubMed ID: 17391728 [TBL] [Abstract][Full Text] [Related]
24. Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival. Brenne K; Nymoen DA; Hetland TE; Trope' CG; Davidson B Hum Pathol; 2012 Apr; 43(4):496-505. PubMed ID: 21855111 [TBL] [Abstract][Full Text] [Related]
25. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis. Li ZR; Wang Z; Zhu BH; He YL; Peng JS; Cai SR; Ma JP; Zhan WH Surg Today; 2007; 37(8):646-51. PubMed ID: 17643206 [TBL] [Abstract][Full Text] [Related]
26. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis. Wang Y; Li ZF; He J; Li YL; Zhu GB; Zhang LH; Li YL Int J Colorectal Dis; 2007 Oct; 22(10):1179-84. PubMed ID: 17440740 [TBL] [Abstract][Full Text] [Related]
27. APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival. Tuft Stavnes H; Nymoen DA; Hetland Falkenthal TE; Kærn J; Tropé CG; Davidson B Am J Clin Pathol; 2014 Jul; 142(1):51-7. PubMed ID: 24926085 [TBL] [Abstract][Full Text] [Related]
28. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival. Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507 [TBL] [Abstract][Full Text] [Related]
29. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo. Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731 [TBL] [Abstract][Full Text] [Related]
30. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma. Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637 [TBL] [Abstract][Full Text] [Related]
31. Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration. Vandsemb EN; Bertilsson H; Abdollahi P; Størkersen Ø; Våtsveen TK; Rye MB; Rø TB; Børset M; Slørdahl TS J Transl Med; 2016 Mar; 14():71. PubMed ID: 26975394 [TBL] [Abstract][Full Text] [Related]
32. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma. Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360 [TBL] [Abstract][Full Text] [Related]
33. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma. Xing X; Lian S; Hu Y; Li Z; Zhang L; Wen X; Du H; Jia Y; Zheng Z; Meng L; Shou C; Ji J J Transl Med; 2013 Dec; 11():309. PubMed ID: 24330843 [TBL] [Abstract][Full Text] [Related]
34. Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma. Jin S; Wang K; Xu K; Xu J; Sun J; Chu Z; Lin D; Koeffler PH; Wang J; Yin D Oncotarget; 2014 Jun; 5(11):3685-96. PubMed ID: 25003523 [TBL] [Abstract][Full Text] [Related]
35. High GOLPH3 expression is associated with a more aggressive behavior of epithelial ovarian carcinoma. Ma Y; Ren Y; Zhang X; Lin L; Liu Y; Rong F; Wen W; Li F Virchows Arch; 2014 Apr; 464(4):443-52. PubMed ID: 24458516 [TBL] [Abstract][Full Text] [Related]
36. Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions. Slipicevic A; Holth A; Hellesylt E; Tropé CG; Davidson B; Flørenes VA Gynecol Oncol; 2014 Oct; 135(1):118-24. PubMed ID: 25093290 [TBL] [Abstract][Full Text] [Related]
37. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863 [TBL] [Abstract][Full Text] [Related]
38. Physiological and oncogenic roles of the PRL phosphatases. Hardy S; Kostantin E; Hatzihristidis T; Zolotarov Y; Uetani N; Tremblay ML FEBS J; 2018 Nov; 285(21):3886-3908. PubMed ID: 29770564 [TBL] [Abstract][Full Text] [Related]
39. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells. Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241 [TBL] [Abstract][Full Text] [Related]
40. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma. Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]